Neurogene Q3 EPS $(1.05) Beats $(1.36) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.05) per share which beat the analyst consensus estimate of $(1.36) by 22.79 percent. This is a 6.06 percent decrease over losses of $(0.99) per share from the
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.05) per share which beat the analyst consensus estimate of $(1.36) by 22.79 percent. This is a 6.06 percent decrease over losses of $(0.99) per share from the same period last year.
